Ali T Taher Selected Research

Factor VIIa (Activated Factor VII)

12/2010	Use of recombinant activated factor VII for intractable bleeding in patients without hemophilia: A developing country tertiary care center's experience.
9/2007	Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali T Taher Research Topics

Disease

63	Thalassemia 05/2024 - 01/2006
51	Iron Overload 05/2024 - 01/2009
25	beta-Thalassemia (Cooley's Anemia) 01/2023 - 09/2006
20	Anemia 05/2024 - 07/2006
12	Thrombosis (Thrombus) 08/2021 - 01/2004
10	Sickle Cell Anemia (Hemoglobin S Disease) 12/2022 - 12/2009
6	Hemolytic Anemia 01/2024 - 07/2006
5	Neoplasms (Cancer) 01/2022 - 04/2012
5	Osteoporosis 01/2018 - 09/2006
5	Infections 01/2016 - 01/2004
4	Hemorrhage 01/2024 - 09/2007
4	Pain (Aches) 10/2022 - 09/2006
4	COVID-19 01/2022 - 01/2020
4	Thrombophilia 07/2021 - 11/2012
4	Hepatitis C 01/2018 - 07/2008
4	Venous Thromboembolism 01/2018 - 12/2008
4	Siderosis 01/2017 - 01/2011
3	Proteinuria 08/2023 - 01/2012
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 05/2017
3	Fatigue 01/2023 - 07/2014
3	Arthralgia (Joint Pain) 10/2022 - 03/2011
3	Disease Progression 06/2022 - 01/2008
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 09/2008
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2021 - 01/2020
3	Leg Ulcer 12/2014 - 03/2010
3	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2012 - 03/2010
3	Hypothyroidism 07/2012 - 03/2010
3	Budd-Chiari Syndrome (Budd Chiari Syndrome) 08/2010 - 10/2005
2	Fever (Fevers) 10/2023 - 08/2023
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2023 - 08/2023
2	alpha-Thalassemia 01/2023 - 01/2023
2	Headache (Headaches) 10/2022 - 07/2014
2	Hemoglobinopathies 05/2022 - 01/2018
2	Pulmonary Embolism 01/2022 - 10/2010
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 08/2020 - 12/2009
2	Heart Failure 01/2018 - 03/2010
2	Abdominal Pain (Pain, Abdominal) 07/2014 - 03/2008
2	Priapism 01/2014 - 11/2013
2	Seizures (Absence Seizure) 08/2013 - 07/2009
2	Essential Thrombocythemia 06/2013 - 08/2010
2	Pulmonary Hypertension 04/2012 - 11/2011
2	Thrombocytopenia (Thrombopenia) 03/2012 - 07/2006
2	Hemolysis 01/2012 - 01/2004
2	Hemophilia A (Haemophilia) 12/2010 - 09/2007
2	Multiple Myeloma 03/2009 - 06/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2008 - 06/2006
1	von Willebrand Diseases (von Willebrand's Disease) 01/2024
1	Diarrhea 08/2023
1	Pharyngitis (Sore Throat) 08/2023

Drug/Important Bio-Agent (IBA)

55	IronIBA 05/2024 - 07/2008
19	Deferasirox FDA Link 10/2023 - 12/2009
18	Hemoglobins (Hemoglobin)IBA 08/2023 - 12/2011
14	GlobinsIBA 01/2024 - 01/2006
11	Ferritins (Ferritin)IBA 01/2019 - 01/2009
9	luspaterceptIBA 07/2023 - 01/2020
7	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023 - 03/2010
7	Chelating AgentsIBA 01/2018 - 01/2011
6	DeferiproneIBA 01/2016 - 01/2011
5	TabletsIBA 10/2023 - 05/2017
5	Deferoxamine (Desferal)FDA LinkGeneric 01/2016 - 02/2012
4	Fetal Hemoglobin (Hemoglobin F)IBA 06/2022 - 01/2012
4	Antiphospholipid AntibodiesIBA 08/2021 - 01/2020
4	HepcidinsIBA 10/2018 - 04/2012
4	factor V LeidenIBA 03/2015 - 10/2005
4	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2010 - 01/2004
3	CreatinineIBA 05/2024 - 12/2017
3	LigandsIBA 12/2021 - 01/2019
3	AntibodiesIBA 03/2021 - 07/2006
3	Prothrombin (Factor II)IBA 10/2010 - 01/2004
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 08/2023
2	von Willebrand FactorIBA 01/2024 - 03/2009
2	Factor VIII (Coagulation Factor VIII)IBA 01/2024 - 03/2009
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	AnticoagulantsIBA 07/2021 - 01/2018
2	Phospholipids (Phosphatides)FDA LinkGeneric 03/2021 - 01/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2021 - 01/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2014
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021 - 11/2012
2	Growth Differentiation Factor 15IBA 01/2017 - 12/2011
2	2,2-dimethylbutyric acidIBA 07/2014 - 11/2013
2	Transferrin (beta 2 Transferrin)IBA 01/2012 - 12/2011
2	Factor VIIa (Activated Factor VII)IBA 12/2010 - 09/2007
2	Antiviral Agents (Antivirals)IBA 06/2010 - 10/2009
2	Thalidomide (Thalomid)FDA Link 12/2009 - 06/2007
2	Factor V (Coagulation Factor V)IBA 12/2008 - 04/2006
2	Zoledronic Acid (Zometa)FDA Link 11/2008 - 09/2006
1	BESIBA 01/2024
1	thiaclopridIBA 10/2023
1	Transaminases (Aminotransferases)IBA 08/2023
1	Hemoglobin EIBA 01/2023
1	hemoglobin Bart'sIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023

Therapy/Procedure

31	Therapeutics 01/2024 - 01/2004
28	Chelation Therapy (Therapy, Chelation) 05/2024 - 01/2009
11	Blood Transfusion (Blood Transfusions) 08/2023 - 01/2009
11	Splenectomy 01/2023 - 12/2005
5	Drug Therapy (Chemotherapy) 12/2009 - 01/2008
3	Erythrocyte Transfusion 07/2023 - 11/2021
3	Hematopoietic Stem Cell Transplantation 11/2021 - 01/2017
1	Transjugular Intrahepatic Portasystemic Shunt 01/2023